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The NB-OK 1 human neuroblastoma cell line expressed muscarinic cholinergic receptors that could be la- 
beled with N-PH]methylscopolamine (a nonselective antagonist). 80% of these receptors showed high affini- 
ty for pirenzepine, i.e. belonged to the Ml subtype found in neuronal tissues. Their binding properties were 
identical to those of rat hippocampus Ml receptors, and differed from those of rat pancreas and heart mus- 
carinic receptors. The remaining (20%) muscarinic receptors showed low affinity for pirenzepine and AF-DX 
116, being therefore of an M2B (or B) subtype, and were similar to rat pancreatic receptors. 
Muscarinic receptor; Receptor binding assay; Receptor subtype; Neuroblastoma; 
(NB-OK cell, Human, Rat pancreas, Rat hippocampus) 
1. INTRODUCTION 
The NB-OK 1 cell line is a human 
neuroblastoma synthesizing and secreting the 
neuropeptide vasoactive intestinal polypeptide 
(VIP) and its precursor [l]. Other neuroblastoma 
cell lines, known to possess muscarinic receptors 
[2,3], provide interesting models to investigate the 
regulation of receptor synthesis, degradation and 
biological activity (see e.g. [2-61). We therefore 
decided to test whether the NB-OK 1 cell line, like 
other neuroblastomas, expressed enough musca- 
rinic receptors to allow binding studies. 
Since at least three subtypes of muscarinic recep- 
tors have been described in mammalian tissues, we 
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compared the binding properties of two selective 
ligands (pirenzepine and AF-DX 116) in order to 
identify the subtype(s) present in NB-OK 1 cells. 
Indeed, pirenzepine recognizes ‘Ml’ or ‘A’ recep- 
tors with high affinity [7]; AF-DX 116 has a high 
affinity for M~Q (or C) receptors [8], and Mv (or 
B) receptors show a low affinity for the two selec- 
tive antagonists [8]. Finally, we compared the an- 
tagonist binding properties of these human 
receptors with those of similar Ml receptors, la- 
beled by [3H]pirenzepine, in rat hippocampus 
homogenates [9]. 
2. MATERIALS AND METHODS 
The NB-OK 1 cell line was a generous gift from 
Dr N. Yanaihara (Shizuoka College of Pharmacy, 
Shizuoka, Japan). N-[3H]Methylscopolamine 
(70 Ci/mmol) was obtained from the Radio- 
chemical Centre (Amersham, Bucks, England) and 
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[3H]pirenzepine (80 Ci/mmol) from New England 
Nuclear (Dreieich, FRG). Pirenzepine was a 
generous gift from Dr R. Hammer (Institute de 
Angeli, Milano, Italy), 4-DAMP methobromide 
from Dr R. Barlow (University of Bristol, 
England), and hexahydrosiladifenidol (HHSiD) 
from Dr G. Lambrecht (Frankfu~ am Main, 
FRG). We thank Dr A. Giachetti for helping us to 
obtain AF-DX 116 from Boehringer Ingelheim 
(FRG). Dexetimide and dicyclomine were generous 
gifts from, respectively, Janssen Pharmaceutics 
(Beerse, Belgium) and Merell-Dow (Brussels, 
Belgium). Trihexyphenidyl and atropine were ob- 
tained from Sigma (St Louis, MO, USA). All cell 
culture products were from Gibco (Ghent, 
Belgium). 
In binding studies, we used with NB-OK 1 
homogenate 8OOpg protein and ~3H]NMS, and 
with hippocampus homogenates either 40 pg pro- 
tein and [3H]NMS or 200,ug protein and 
[3H]pirenzepine. All homogenates were incubated 
for 2 h at 25°C in 1.2 ml of 50 mM sodium 
phosphate buffer (pH 7.4) enriched with 2 mM 
MgCl2 and 1% bovine serum albumin. Atropine 
(1 PM) was used to define nonspecific binding. The 
incubation was terminated by filtration, as de- 
scribed in 191. 
3. RESULTS AND DISCUSSION 
3.1. Binding kinetics 
The NB-OK 1 cell line was cultured as described 
in [l]. For studying the binding properties of 
muscarinic receptors, cells were collected in 
phosphate buffered (pH 7.4) saline (20 mM 
sodium phosphate, 150 mM sodium chloride) 
enriched with 1 mM EDTA; homogenized in 
20 mM Tris-HCl buffer (pH 7.5) enriched with 
5 mM MgClz, at a final concentration of 15 mg 
protein/ml, and stored in liquid nitrogen. 
[3H]NMS binding to NB-OK 1 cell homogenates 
was concentration- and time-dependent, as shown 
in fig.1 (left panel). [3H]NMS dissociation was 
biphasic, with a half-life of 12 min at 25°C. These 
dissociation kinetics could be fitted by assuming 
that 80~0 of ~3H]NMS-re~ptor complexes had a 
koff of 0.10 min-‘, typical of Ml receptors, and 
20% a koff of 0.02 min-‘, typical of M2$3 receptors 
(cf. 191). 
Hippocampus homogenates were obtained as 3.2. E~~iIibrium binding 
described in [9]. [3H]NMS saturation curves yielded a linear 
40 
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Fig. 1. (Left) Specific binding of [3H]NMS at three different concentrations (120 pM, 0; 180 pM, X ; 900 pM, A) to 
NB-OK 1 homogenates measured as a function of time. (Right) [3H]NMS was preincubated with NB-OK I homogenates 
for 2 h before isotopic dilution. Residual specific binding was measured as a function of time. This experiment is 
representative of 2 others. 
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Fig.2. (Left) 60-loo0 pM [3H]NMS specific binding was measured at equilibrium. The results are presented according 
to Scatchard [lo]. (Right) Specific [3H]NMS (800 PM) binding was measured in the absence or presence of the indicated 
concentrations of pirenzepine (0) or AF-DX 116 (A). This experiment is representative of 9 others. 
Scatchard plot [lo]. The Kd value was 120 pM, and 
maximal binding varied between 50 and 
100 fmol/mg neuroblastoma cell lines [2-61. 
Competition curves by the two selective an- 
tagonists pirenzepine and AF-DX 116, analyzed as 
in [9], indicated that 80% of the receptors had a 
high affinity for pirenzepine (Ki 5 nM), i.e. were of 
the Ml type, the remaining 20% showing a low af- 
finity (Ki 140 nM), i.e. being of the M2 type (fig.2, 
right panel). All receptors had a low affinity for 
AF-DX 116 (Ki 500 nM). The NB-OK 1 receptors 
Table 1 
Dissociation constants (ZCi value in nM) of 8 muscarinic 
antagonists for NB-OK 1 cell receptors labeled by 
[3H]NMS, rat brain Ml receptors labeled by 
13H]pirenzepine, and rat heart and rat pancreas 
receptors labeled by [3H]NMS (as in [ll]) 
NB-OK 1 Brain Ml Heart Pancreas 
Atropine 0.3 0.27 1.0 0.4 
Pirenzepine 7 5 350 140 
Dexetimide 0.15 0.14 1.50 0.2 
Dicyclomine 3.0 3.0 56.0 3.0 
Trihexyphenidyl 6.0 5.0 36.0 14.0 
4-DAMP 0.9 0.9 9.0 1.2 
HHSiD 16 16 200 17 
AF-DX 116 500 500 50 1600 
AF-OX 116 
rlf 7 1 
-9 -8 -7 -6 -5 -4 
[ANTAGONIST] Ilog MI 
Fig.3. [3H]NMS binding to NB-OK 1 (open symbols) 
and hippocampus (closed symbols) was measured in the 
absence or presence of pirenzepine (circles) or AF-DX 
116 (triangles) at a 100 pM (top panel) or 1600 pM 
(bottom panel) total tracer concentration. This 
experiment is representative of 3 others. 
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consisted, therefore, of a majority of Ml and a 
minority of M26 receptors. 
We next compared the binding properties of NB- 
OK 1 cell receptors with those of rat hippocampus 
Ml receptors labeled by [3H]pirenzepine [9], and 
those of rat receptors labeled by [3H]NMS in heart 
(M2cu or C-like) and pancreas (M26 or B-like) 
homogenates (as in [ 111). The 8 antagonists tudied 
presented the same affinity towards NB-OK 1 
muscarinic receptors and the subclass of hip- 
pocampus receptors labeled by [3H]pirenzepine; 
the selectivity pattern was clearly different in rat 
heart and rat pancreas (table 1). 
The proportion of Ml receptors found in NB- 
OK 1 cells was unusually large: by comparison, we 
found 55% of Ml receptors, 20% of C receptors 
and 25% of B receptors [9] in rat hippocampus 
(fig.3). 
4. CONCLUSION 
The NB-OK 1 human neuroblastoma expressed 
muscarinic cholinergic receptors showing nearly 
homogeneous binding properties, as 80% of these 
receptors had Ml receptor binding properties. The 
binding pattern of 8 muscarinic antagonists to 
these NB-OK 1 receptors differed from that in 
heart and pancreas muscarinic receptors and was 
identical to the binding pattern of receptors labeled 
by [3H]pirenzepine in various rat brain regions [9]. 
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